We highlight several often-neglected additional therapeutic advantages of GLP-1 RAs, such as their ability to decrease neuroinflammation and immune senescence, along with the potential for GLP-1 RAs to help lower vascular stiffness and combat sarcopenia, both of which are major factors affecting mobility, resilience, and overall health in older individuals
This is a critical research gap
Based on the research to date, the risk of severe hypoglycemia increases only when tirzepatide is used as an add-on to other glucose-lowering agents
Side Effects and Safety at the 40-Unit Dosage Level At 40 units (2 mg), semaglutide is generally well tolerated by most patients, though gastrointestinal side effects such as nausea, vomiting, or diarrhea may occur, particularly if you escalated too quickly or have underlying gastroparesis
Zhang WY, Hu XF, Wan N, et al
Thats a critical distinction, because it means these patches do not actually contain the active GLP-1 medications responsible for the weight-loss effects seen in clinical trials